		<rss version="2.0">
		<channel>
		<title>Avandia News RSS Feed - Lawyer Seek Litigation</title>
		<link>http://www.lawyerseek.com/Practice/In-The-News-C20/Avandia-P41/News/</link>
		<description>Avandia
Avandia, which has the generic name of rosiglitazone maleate, is used to treat patients suffering from type 2 diabetes, also referred to as adult onset diabetes. Avandia is manufactured by GlaxoSmithKline. It is a member of a relatively new class of diabetes medication called thiazolidinediones. Rezulin, also in this class of drugs, was pulled from the market as a result of several deaths.  Both drugs treat type 2 diabetes by helping to control the body&#39;s level of blood sugar by decreasing insulin resistance, which, in turn, decreases the need for additional ... </description>
		<language>en-us</language>
		
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/In-The-News-C20/Avandia-P41/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature.</description>			
			</item>			
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/In-The-News-C20/Avandia-P41/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature</description>			
			</item>			
					<item>
			<title>Health Canada issues diabetes drug warning</title><link>http://www.lawyerseek.com/Practice/In-The-News-C20/Avandia-P41/News/</link><description>Two drugs used to treat Type-2 diabetes may lead to new cases or worsening of a vision problem called macular edema, Health Canada has warned.</description>			
			</item>			
				
		</channel>
		</rss> 
		